Sign Up Today and Learn More About Berkeley Lights Stock
Invest in or calculate the value of your shares in Berkeley Lights or other pre-IPO companies through EquityZen's platform.
Berkeley Lights Stock
Cell Manipulation for Personalized Therapies
Berkeley Lights, Inc. (BLI) is a platform for single cell manipulation that allows for researchers to analyze cells. It aims to provide platforms that automate the manipulation and analysis of cells. The Beacon platform, the company's flagship product, is suited for cell line development, antibody discovery, gene editing, and antibody engineering workflows. The platform uses optofluidics and light-based technology to automate the work of cloning, culturing and sorting specific cells from biological samples. By automating these processes, they aim to cut the time and human labor needed to develop cell lines, discover and engineer antibodies, and do gene editing.
About Berkeley Lights Stock
Founded
2011
Headquarters
Emeryville, CA, US
Total Funding
227M
Industries
Software, Artificial Intelligence, Data and Analytics
Berkeley Lights, Inc. (BLI) is a platform for single cell manipulation that allows for researchers to analyze cells. It aims to provide platforms that automate the manipulation and analysis of cells. The Beacon platform, the company's flagship product, is suited for cell line development, antibody discovery, gene editing, and antibody engineering workflows. The platform uses optofluidics and light-based technology to automate the work of cloning, culturing and sorting specific cells from biological samples. By automating these processes, they aim to cut the time and human labor needed to develop cell lines, discover and engineer antibodies, and do gene editing.
On June 26, 2020, Berkeley Lights filed to go public. Click here to see Berkeley Light's IPO paperwork.
The company was founded in 2011 in Emeryville, California.
Berkeley Lights Press Mentions
Stay in the know about the latest news on Berkeley Lights
All About the Berkeley Lights Stock IPO
nanalyze • Jul 05, 2020
Abveris Announces Human Antibody Discovery Partnership with Nkarta using the Trianni Mouse® on the Berkeley Lights Beacon®
GlobeNewswire • May 12, 2020
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies T
PR Newswire • Apr 27, 2020
How the coronavirus validated Berkeley Lights' technology and its supply chain
San Francisco Business Times • Mar 13, 2020
Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody Therapeutics
PR Newswire • Mar 09, 2020
Investors in Berkeley Lights
Discover investors in Berkeley Lights stock and explore their portfolio companies
Berkeley Lights Management
Leadership team at Berkeley Lights
Chief Executive Officer
Eric Hobbs
Chief Financial Officer
Shaun Holt
Join now and verify your accreditation status to gain access to:
- Berkeley Lights current valuation
- Berkeley Lights stock price
- Available deals in Berkeley Lights and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Berkeley Lights stock?
Accredited investors can buy pre-IPO stock in companies like Berkeley Lights through EquityZen funds. These investments are made available by existing Berkeley Lights shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Berkeley Lights stock?
Shareholders can sell their Berkeley Lights stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
